首页> 美国卫生研究院文献>Oxford Open >2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia

【2h】

2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia

机译：2403.达托霉素与头孢洛林或奥沙西林联合治疗抗耐甲氧西林金黄色葡萄球菌（MRSA）菌株的比较引起持久性细菌血症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundIncreasing evidence suggests that daptomycin (DAP) demonstrates in vitro synergy in combination with other anti-staphylococcal agents, including ceftaroline (CPT) and oxacillin (OXA), against MRSA. Nevertheless, optimal combinations remain undefined. Here, our objective was to compare DAP in combination with CPT or OXA against MRSA bloodstream isolates collected from patients with persistent bacteremia despite >7 days of vancomycin treatment.

机译：背景技术越来越多的证据表明达托霉素（DAP）与其他抗葡萄球菌药物（包括头孢洛林（CPT）和奥沙西林（OXA））联合使用具有针对MRSA的体外协同作用。然而，最佳组合仍然不确定。在这里，我们的目的是将DAP联合CPT或OXA与从≥7天接受万古霉素治疗的持续性菌血症患者收集的MRSA血流分离物进行比较。

著录项

期刊名称 Oxford Open
作者
Jeannette Bouchard; Chelsea Jones; Ellen Kline; Louise-Marie Oleksiuk; Ryan K Shields;
展开▼
作者单位

展开▼
年(卷),期 -1(5),Suppl 1
年度 -1
页码 S717–S718
总页数 2
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
专利

1. Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline [J] . Progress in Artificial Intelligence . 2020,第1期

机译：比较Ceftaroline Plus vancomycin或Daptomycin组合治疗对成年人的单一疗法的复杂和延长的甲氧西林耐药葡萄球菌血糖药物最初用补充头孢尔碱治疗
2. Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline [J] . Omar Ahmad, Timothy N. Crawford, Thein Myint Infectious Diseases and Therapy . 2020,第1期

机译：比较Ceftaroline Plus vancomycin或Daptomycin组合治疗与成人单药治疗复杂和延长的甲氧西林耐金黄色葡萄球菌菌血症的结果，最初用辅作治疗
3. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). [J] . Yang SJ, Xiong YQ, Boyle Vavra S, Antimicrobial agents and chemotherapy. . 2010,第8期

机译：达托霉素-奥沙西林组合治疗由耐达西霉素的耐甲氧西林金黄色葡萄球菌菌株引起的实验性心内膜炎，并伴有不断增长的奥沙西林敏感性（“跷跷板效应”）。
4. Synthesis and Characterization of Biogenic Selenium Nanoparticles with Antimicrobial Properties Made by Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli and Pseudomonas aeruginosa. [C] . David Medina, Thomas J. Webster Society for Biomaterials annual meeting and exposition . 2018

机译：金黄色葡萄球菌，耐甲氧西林金黄色葡萄球菌（MRSA），大肠杆菌和铜绿假单胞菌制成的具有抗菌特性的生物硒纳米粒子的合成与表征。
5. Mapping the genetic evolution of daptomycin non-susceptibility in methicillin-resistant Staphylococcus aureus (MRSA) [D] . Mishra, Smruti 2019

机译：绘制耐甲氧西林金黄色葡萄球菌（MRSA）中达托霉素非敏感性的遗传进化图
6. Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia [O] . Nicolas Cortes-Penfield, Nora T. Oliver, Andrew Hunter, -1

机译：达托霉素和达托霉素-头孢洛林联合治疗持久性耐甲氧西林金黄色葡萄球菌菌血症
7. 2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia [O] . Jeannette Bouchard, Chelsea Jones, Ellen Kline, 2018

机译：2403.与甲氧丙氨素或牛奶蛋白对甲氧西林葡萄球菌（MRSA）分离株导致持久性菌血症的达氨霉素组合疗法的比较

2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia

摘要

著录项

相似文献

相关主题

期刊订阅